| Literature DB >> 36132193 |
Atika Khurana1, Christopher M Loan2, Dan Romer3.
Abstract
Adolescent decisions, especially in novel contexts, are often guided by affective evaluations (i.e., feelings associated with a stimulus) rather than knowledge of the risks and probabilities of different outcomes. In this study, we used the affect-driven exploration (ADE) model to illustrate how affective evaluations can play a critical role in driving early use of cigarettes, as well as the adaptive function of the resulting experiential learning in informing future affect and cigarette use. We analyzed five waves of data collected from a large, diverse community sample of adolescents who were followed from early to late adolescence (N = 386; 50.9% female; Baseline age = 11.41 ± 0.88 years) during years 2004-2010 to model trajectories of positive affect and risk perceptions (associated with cigarette use) and examined the associations of these trajectories with their self-reported cigarette use and dependence symptoms. Consistent with the ADE model, early initiators reported higher levels of positive affect at baseline, which we argue may have led them to try cigarettes. Notably, most early initiators reported a decline in positive affect over time, suggesting an experience-based shift in affective evaluations associated with cigarette use. Risk perceptions associated with cigarette use did not emerge as a significant predictor of cigarette use or subsequent dependence. Therefore, for deterring adolescent cigarette use, efforts to influence affect (through graphic warning labels and other media) may be more effective than directly influencing risk perceptions. Despite the affective basis for initiating cigarette use, few adolescents engaged in early use (N = 20) or developed symptoms of dependence (N = 25). Majority of those who engaged in early cigarette use showed a decline in positive affect, with corresponding increase in risk perceptions over time. Some early users may indeed continue to engage in cigarette use, but this is likely driven by the addictive properties of the drug. Overall these findings challenge the popular stereotype of impulsive and emotionally reactive behaviors during adolescence, and suggest a more nuanced interpretation of adolescent risk behavior.Entities:
Keywords: adolescence; affect; cigarette use; risk perception; tobacco use disorder
Year: 2022 PMID: 36132193 PMCID: PMC9484548 DOI: 10.3389/fpsyg.2022.887021
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Hypothesized Model. Single-headed straight lines represent regression pathways, double-headed curved lines represent covariances. Dashed pathways signify effects that are hypothesized to be non-significant. Manifest variables corresponding to the latent intercepts and slopes were omitted from the diagram for clarity. Effects of covariates was assessed on intercepts and slopes of affect and risk, and on cigarette use at T4. These pathways have also been omitted for clarity.
Descriptive statistics and endorsement pattern for affect toward and perceived risk of cigarette use T1–T3.
| Affect | Perceived risk | ||||||||
| Mean (SD); range | Very bad | Some-what bad | Some-what good | Very good | Mean (SD); range | No | A little | Yes | |
| T1 | 1.24 (0.52); 1–4 | 295 | 64 | 10 | 2 | 2.88 (0.45); 1–3 | 18 | 10 | 343 |
| T2 | 1.35 (0.67); 1–4 | 269 | 68 | 20 | 7 | 2.86 (0.45); 1–3 | 16 | 18 | 330 |
| T3 | 1.50 (0.76); 1–4 | 229 | 87 | 35 | 8 | 2.92 (0.32); 1–3 | 6 | 15 | 338 |
Parameter estimates from unconditional parallel process model.
| Unstand. estimate | 95% lower CI | 95% upper CI |
| Standard. estimate | |
| Covariances | |||||
| Intercept affect ↔ Slope affect | –0.007 | –0.046 | 0.031 | 0.709 | –0.065 |
| Intercept affect ↔ Intercept risk | –0.006 | –0.029 | 0.018 | 0.638 | –0.035 |
| Intercept affect ↔ Slope risk | –0.011 | –0.027 | 0.005 | 0.193 | –0.143 |
| Slope affect ↔ Intercept risk | –0.002 | –0.014 | 0.010 | 0.755 | –0.018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Variances | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Slope risk | 0.033 | –0.0003 | 0.067 | 0.052 | 1.000 |
| Mean values | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Slope risk | 0.023 | –0.025 | 0.275 | 0.102 | 0.125 |
Bold and shaded values signify estimates significant at p < 0.05.
Parameter estimates from full model.
| Direct paths | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intercept risk → Cigarette use (T4) | –0.120 | –0.243 | 0.004 | 0.078 | –0.065 |
| Slope risk → Cigarette use (T4) | –0.270 | –0.846 | 0.307 | 0.352 | –0.067 |
| Early cigarette use (T1) → Cigarette use (T4) | 0.308 | –0.288 | 0.903 | 0.311 | 0.096 |
|
|
|
|
|
| |
| Early cigarette use → TUD symptoms (T5) | 0.037 | –0.365 | 0.438 | 0.858 | 0.013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Early cigarette use (T1) → Intercept risk | –0.171 | –0.424 | 0.082 | 0.186 | –0.099 |
| Early cigarette use (T1) → Slope risk | 0.106 | –0.028 | 0.241 | 0.122 | 0.134 |
|
| |||||
| Intercept affect ↔ Slope affect | –0.006 | –0.043 | 0.031 | 0.732 | –0.065 |
| Intercept affect ↔ Intercept risk | 0.008 | –0.011 | 0.027 | 0.413 | 0.058 |
|
|
|
|
|
|
|
| Slope affect ↔ Intercept risk | –0.001 | –0.013 | 0.011 | 0.886 | –0.009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Slope risk | 0.030 | –0.001 | 0.062 | 0.060 | 0.941 |
Bold and shaded values signify estimates significant at p < 0.05.
Selected indirect effects; 95% confidence intervals (CIs) produced by using the adjusted bootstrap percentile method to adjust for bias in the distribution of indirect effects.
| Indirect pathways of influence | Unstan. | 95% lower CI | 95% upper CI | Stand. Est. |
|
| ||||
| Intercept affect → Cigarette use (T4) → TUD symptoms (T5) |
|
|
|
|
| Slope affect → Cigarette use (T4) → TUD symptoms (T5) |
|
|
|
|
| Total indirect effect of affect on cigarette use T4 [(Intercept affect → Cig use T4) + (Slope affect → Cig use T4)] |
|
|
|
|
| Total indirect effect of affect on TUD symptoms T5 [(Intercept affect → Cig use T4 → TUD T5) + (Slope affect → Cig use T4→TUD T5)] |
|
|
|
|
|
| ||||
| Intercept risk → Cigarette use (T4) → TUD symptoms (T5) | –0.059 | –0.173 | 0.030 | –0.037 |
| Slope risk → Cigarette use (T4) → TUD symptoms (T5) | –0.133 | –0.607 | 0.292 | –0.039 |
| Total indirect effect of risk on cigarette use T4 [(Intercept risk → Cig use T4) + (Slope risk → Cig Use T4)] | –0.389 | –1.327 | 0.615 | –0.132 |
| Total indirect effect of Risk on TUD symptoms T5 [(Intercept risk → Cig use T4→ TUD T5) + (Slope risk → Cig use T4→ TUD T5)] | –0.192 | –0.691 | 0.281 | –0.076 |
|
| ||||
| Early cigarette use (T1) →Intercept affect → Cigarette use (T4) |
|
|
|
|
| Early cigarette use →Slope affect → Cigarette use (T4) |
|
|
|
|
| Total indirect effect of early cigarette use T1 on cigarette use T4 through affect [(Early cigarette use →Intercept affect → Cig use) + (Early cigarette use →Slope affect → Cig use)] | 0.315 | –0.501 | 1.233 | 0.098 |
| Early cigarette use T1 → Intercept affect → Cig use T4 → TUD T5 |
|
|
|
|
| Early cigarette use T1 → Slope affect → Cig use T4 → TUD T5 |
|
|
|
|
| Total indirect effect of early cigarette use T1 on TUD through affect [(Early cigarette use → Intercept affect → Cig use T4 → TUD T5) + (Early cigarette use → Slope affect → Cig use T4 → TUD T5)] | 0.155 | –0.203 | 0.675 | 0.057 |
| Early cigarette use → Intercept risk → Cigarette use T4 | 0.020 | –0.007 | 0.114 | 0.006 |
| Early cigarette use →Slope risk → Cigarette use T4 | –0.029 | –0.210 | 0.038 | –0.009 |
| Total indirect effect of early cigarette use T1 on cigarette use T4 through risk [(Early cigarette use →Intercept risk → Cig use) + (Early cigarette use →Slope risk → Cig use)] | –0.008 | –0.155 | 0.076 | –0.003 |
| Early cigarette use T1 → Intercept risk → Cigarette use T4 → TUD T5 | 0.010 | –0.003 | 0.059 | 0.004 |
| Early cigarette use T1 → Slope risk → Cigarette use T4 → TUD T5 | –0.014 | –0.112 | 0.017 | –0.005 |
| Total indirect effect of early cigarette use T1 on TUD T5 through risk [(Early cigarette use → Intercept risk → Cig use T4 → TUD T5) + (Early cigarette use → Slope risk → Cig use T4 → TUD T5)] | –0.004 | –0.078 | 0.037 | –0.001 |
All estimates were created with 5,000 bootstrap draws. Bold and shaded values signify estimates significant at p < 0.05.
Demographic parameter estimates from full model.
| Direct paths | ||||||
|
|
|
|
|
|
|
|
| Cigarette use (T4) | Sex (Female) | 0.001 | –0.133 | 0.134 | 0.994 | <0.001 |
| Non-Hispanic Black |
|
|
|
|
| |
| Hispanic | 0.238 | –0.061 | 0.537 | 0.118 | 0.094 | |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
| Intercept affect | Age | 0.037 | –0.015 | 0.088 | 0.160 | 0.076 |
| Sex (Female) | –0.021 | –0.114 | 0.073 | 0.663 | –0.024 | |
| Non-Hispanic Black | 0.107 | –0.014 | 0.227 | 0.083 | 0.110 | |
| Hispanic | –0.021 | –0.184 | 0.142 | 0.802 | –0.014 | |
| Other race/ethnicity | –0.037 | –0.159 | 0.085 | 0.553 | –0.025 | |
| SES | 0.000 | –0.003 | 0.003 | 0.964 | 0.002 | |
| Slope affect | Age | 0.038 | –0.003 | 0.079 | 0.071 | 0.115 |
| Sex (Female) | –0.024 | –0.100 | 0.051 | 0.527 | –0.041 | |
| Non-Hispanic Black | –0.005 | –0.102 | 0.092 | 0.918 | –0.008 | |
| Hispanic | 0.002 | –0.155 | 0.160 | 0.978 | 0.002 | |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
| Intercept risk | Age | –0.013 | –0.065 | 0.038 | 0.611 | –0.030 |
| Sex (Female) | 0.039 | –0.055 | 0.133 | 0.417 | 0.050 | |
|
|
|
|
|
|
| |
| Hispanic | 0.051 | –0.079 | 0.182 | 0.440 | 0.037 | |
| Other race/ethnicity | 0.014 | –0.105 | 0.134 | 0.814 | 0.010 | |
|
|
|
|
|
|
| |
| Slope risk | Age | 0.006 | –0.021 | 0.033 | 0.661 | 0.030 |
| Sex (Female) | –0.036 | –0.088 | 0.017 | 0.184 | –0.099 | |
| Non-Hispanic Black | 0.071 | –0.004 | 0.147 | 0.064 | 0.175 | |
| Hispanic | –0.014 | –0.099 | 0.071 | 0.745 | –0.022 | |
| Other race/ethnicity | 0.021 | –0.053 | 0.095 | 0.581 | 0.033 | |
| SES | –0.001 | –0.002 | 0.001 | 0.434 | –0.054 | |
Bold values signify estimates significant at p < 0.05.
FIGURE 2Final model with standardized path estimates. Bolded estimates with solid lines represent significant paths (p < 0.05), non-bolded estimates and dotted lines represent non-significant (p > 0.05) paths. Covariates, mean structure, and manifest variables for affect and risk not shown.